Cargando…

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer

BACKGROUND: Ovarian cancer (OC) is one of the most lethal gynecologic malignancies and a leading cause of death in the world. Thus, this necessitates identification of prognostic biomarkers which will be helpful in its treatment. METHODS: The gene expression profiles from The Cancer Genome Atlas (TC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Biao, Tan, Guangqing, Ren, Jingyi, Lu, Weiyu, Pervaz, Sadaf, Ren, Xinyi, Otoo, Antonia Adwoa, Tang, Jing, Li, Fangfang, Wang, Yingxiong, Wang, Meijiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920998/ https://www.ncbi.nlm.nih.gov/pubmed/35299734 http://dx.doi.org/10.3389/fonc.2022.830908

Ejemplares similares

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
por: Lu, Weiyu, et al.
Publicado: (2023)

EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
por: Li, Kun, et al.
Publicado: (2022)

The PNA mouse may be the best animal model of polycystic ovary syndrome
por: Ren, Jingyi, et al.
Publicado: (2022)

CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma
por: Zhu, Ningning, et al.
Publicado: (2022)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
por: He, Jinxian, et al.
Publicado: (2023)

Prognostic Significance of Systematic Lymphadenectomy in Patients With Optimally Debulked Advanced Ovarian Cancer: A Meta-Analysis
por: Wang, Yizi, et al.
Publicado: (2020)

A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Development of a Prognostic Model for Ovarian Cancer Patients Based on Novel Immune Microenvironment Related Genes
por: Wang, Wei, et al.
Publicado: (2021)

RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
por: Gelli, Elisa, et al.
Publicado: (2020)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
por: Li, Yike, et al.
Publicado: (2022)

Skin Tumors Rb(eing) Uncovered
por: Costa, Clotilde, et al.
Publicado: (2013)

Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role
por: Zhu, Lizhe, et al.
Publicado: (2020)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer
por: Qiu, Yan, et al.
Publicado: (2021)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
por: Cheng, Meiying, et al.
Publicado: (2023)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
por: Pan, Xue, et al.
Publicado: (2023)

RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC
por: Wang, Qian, et al.
Publicado: (2023)

Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
por: Yang, Miner, et al.
Publicado: (2021)

MAPK Activated Protein Kinase 3 Is a Prognostic-Related Biomarker and Associated With Immune Infiltrates in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer
por: Li, Siting, et al.
Publicado: (2022)

Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
por: Luo, Bin, et al.
Publicado: (2020)

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020)

Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022)

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
por: Zhang, Biao, et al.
Publicado: (2023)

MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients
por: Liu, Yuan-Yuan, et al.
Publicado: (2022)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
por: Liang, Weifeng, et al.
Publicado: (2022)

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas
por: Yang, Biao, et al.
Publicado: (2020)

A prognostic system for epithelial ovarian carcinomas using machine learning
por: Grimley, Philip M., et al.
Publicado: (2021)

Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region
por: Wu, Yunjiao, et al.
Publicado: (2023)

IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
por: Li, Guangyao, et al.
Publicado: (2022)

Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA
por: Li, Yize, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1oloh98mapfhukn91bmebob3ft